Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

BACKGROUND: Biomarkers of therapeutic response and prognosis are needed to assist in the sequencing of treatments for metastatic castration-resistant prostate cancer (CRPC). Previously in a Phase 1 discovery study, we identified 14 circulating microRNAs that were associated with response to docetaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hui-Ming, Mahon, Kate L, Spielman, Calan, Gurney, Howard, Mallesara, Girish, Stockler, Martin R, Bastick, Patricia, Briscoe, Karen, Marx, Gavin, Swarbrick, Alexander, Horvath, Lisa G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396108/
https://www.ncbi.nlm.nih.gov/pubmed/28278515
http://dx.doi.org/10.1038/bjc.2017.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396108/
https://www.ncbi.nlm.nih.gov/pubmed/28278515
http://dx.doi.org/10.1038/bjc.2017.50

Ejemplares similares